Pulmonary manifestations of AIDS-related lymphomas
- Michael Ieong, MD
Michael Ieong, MD
- Assistant Professor of Medicine
- Boston University School of Medicine
- Timothy P Cooley, MD
Timothy P Cooley, MD
- Associate Professor of Medicine
- Boston University School of Medicine
- Section Editors
- John G Bartlett, MD
John G Bartlett, MD
- Editor-in-Chief — Infectious Diseases
- Section Editor — HIV; Pulmonary Infections
- Professor Emeritus
- Johns Hopkins University School of Medicine
- Arnold S Freedman, MD
Arnold S Freedman, MD
- Section Editor — Lymphoproliferative Disorders
- Professor of Medicine
- Harvard Medical School
- Kevin R Flaherty, MD, MS
Kevin R Flaherty, MD, MS
- Section Editor — Interstitial Lung Disease
- Associate Professor of Medicine
- University of Michigan Health System
Human immunodeficiency virus (HIV) infection is associated with an increased incidence of lymphoma. The majority of AIDS-related lymphomas are aggressive, non-Hodgkin lymphoma (NHL) of B cell origin; nearly 60 percent are diffuse large B cell lymphoma and 40 percent Burkitt lymphoma . Most patients show widespread rather than nodal disease, frequently involving the central nervous system (CNS), gastrointestinal tract, lungs, bone marrow, and mucocutaneous tissues. Rare cases of primary pulmonary NHL have been reported [2-4]. NHL in an HIV-infected patient is an AIDS-defining condition.
Hodgkin lymphoma is also more frequent among HIV-infected patients relative to the general population, but overall is less common than NHL, less likely to affect the lungs, and not an AIDS-defining condition [5-9].
Primary effusion lymphoma (PEL) is a rare aggressive tumor seen in HIV infected patients, in association with Kaposi sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8. It has a predisposition to arise in body cavities, such as the pleural space.
The clinical manifestations, diagnosis, and approach to treatment of HIV-associated NHL lymphoma presenting in the chest will be reviewed here. The extra-pulmonary AIDS-related lymphomas, non-AIDS-defining lymphoma, PEL, and Castleman's disease are discussed separately. (See "AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology" and "AIDS-related lymphomas: Primary effusion lymphoma" and "Multicentric Castleman's disease" and "HIV infection and malignancy: Management considerations", section on 'Hodgkin lymphoma'.)
Early in the human immunodeficiency virus (HIV) epidemic, non-Hodgkin lymphoma (NHL) occurred in 2 to 5 percent of HIV-infected patients [10,11]. After the introduction of potent antiretroviral therapy (ART) in the mid-1990s, the incidence of NHL in HIV-infected people peaked around 10 percent but has subsequently dropped to approximately 5 percent . (See "AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology", section on 'Epidemiology'.)To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Lambert AA, Merlo CA, Kirk GD. Human immunodeficiency virus-associated lung malignancies. Clin Chest Med 2013; 34:255.
- Bazot M, Cadranel J, Benayoun S, et al. Primary pulmonary AIDS-related lymphoma: radiographic and CT findings. Chest 1999; 116:1282.
- Cortot AB, Cottin V, Issartel B, et al. [Pulmonary MALT lymphoma revealing AIDS]. Rev Mal Respir 2006; 23:353.
- Ray P, Antoine M, Mary-Krause M, et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998; 158:1221.
- Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337:805.
- Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108:744.
- Lowenthal DA, Straus DJ, Campbell SW, et al. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988; 61:2325.
- Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719.
- Pluda JM, Yarchoan R, Jaffe ES, et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 1990; 113:276.
- DeMario MD, Liebowitz DN. Lymphomas in the immunocompromised patient. Semin Oncol 1998; 25:492.
- Wolf T, Brodt HR, Fichtlscherer S, et al. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2005; 46:207.
- Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med 2015; 163:507.
- Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99:962.
- Guech-Ongey M, Simard EP, Anderson WF, et al. AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010; 116:5600.
- Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991; 68:2466.
- Polish LB, Cohn DL, Ryder JW, et al. Pulmonary non-Hodgkin's lymphoma in AIDS. Chest 1989; 96:1321.
- Loureiro C, Gill PS, Meyer PR, et al. Autopsy findings in AIDS-related lymphoma. Cancer 1988; 62:735.
- Poelzleitner D, Huebsch P, Mayerhofer S, et al. Primary pulmonary lymphoma in a patient with the acquired immune deficiency syndrome. Thorax 1989; 44:438.
- Chilosi M, Zinzani PL, Poletti V. Lymphoproliferative lung disorders. Semin Respir Crit Care Med 2005; 26:490.
- Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11:375.
- Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993; 11:1099.
- Gabarre J, Raphael M, Lepage E, et al. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med 2001; 111:704.
- Zeng W, Lechowicz MJ, Winton E, et al. Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clin Nucl Med 2009; 34:355.
- Lévy R, Colonna P, Tourani JM, et al. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. Leuk Lymphoma 1995; 16:451.
- Yotsumoto M, Hagiwara S, Ajisawa A, et al. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan. Int J Hematol 2012; 96:247.
- Porcel Pérez JM, Rubio Caballero M. [Primary pulmonary lymphoma with pleural involvement as the first sign of adquired immunodeficiency syndrome]. Arch Bronconeumol 2003; 39:433.
- Eisner MD, Kaplan LD, Herndier B, Stulbarg MS. The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Chest 1996; 110:729.
- Corti M, Villafañe MF, Trione N, et al. Primary pulmonary AIDS-related lymphoma. Rev Inst Med Trop Sao Paulo 2005; 47:231.
- Huang H, Lu ZW, Jiang CG, et al. Clinical and prognostic characteristics of pulmonary mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 23 cases in a Chinese population. Chin Med J (Engl) 2011; 124:1026.
- Kim JH, Lee SH, Park J, et al. Primary pulmonary non-Hodgkin's lymphoma. Jpn J Clin Oncol 2004; 34:510.
- Judson MA, Sahn SA. Endobronchial lesions in HIV-infected individuals. Chest 1994; 105:1314.
- Keys TC, Judson MA, Reed CE, Sahn SA. Endobronchial HIV associated lymphoma. Thorax 1994; 49:525.
- Chaouat A, Fraisse P, Kessler R, et al. A life-threatening tracheal localization of lymphoma in a patient with AIDS. Chest 1993; 103:1297.
- Sider L, Weiss AJ, Smith MD, et al. Varied appearance of AIDS-related lymphoma in the chest. Radiology 1989; 171:629.
- Sider L, Horton ES. Pleural effusion as a presentation of AIDS-related lymphoma. Invest Radiol 1989; 24:150.
- Vu H, Vildor E, Reddy S, et al. An unusual presentation of Burkitt lymphoma. South Med J 2009; 102:961.
- Soubani AO, Michelson MK, Karnik A. Pleural fluid findings in patients with the acquired immunodeficiency syndrome: correlation with concomitant pulmonary disease. South Med J 1999; 92:400.
- Armbruster C, Schalleschak J, Vetter N, Pokieser L. Pleural effusions in human immunodeficiency virus-infected patients. Correlation with concomitant pulmonary diseases. Acta Cytol 1995; 39:698.
- Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006; 34:335.
- Collins J, Müller NL, Leung AN, et al. Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings. Radiology 1998; 208:749.
- Heitzman ER. Pulmonary neoplastic and lymphoproliferative disease in AIDS: a review. Radiology 1990; 177:347.
- Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 2010; 30:269.
- Juweid ME. FDG-PET/CT in lymphoma. Methods Mol Biol 2011; 727:1.
- Terasawa T, Lau J, Bardet S, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol 2009; 27:1906.
- Ilica AT, Kocacelebi K, Savas R, Ayan A. Imaging of extranodal lymphoma with PET/CT. Clin Nucl Med 2011; 36:e127.
- Borie R, Wislez M, Antoine M, et al. Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma. Respir Med 2011; 105:1231.
- Song JY, Filie AC, Venzon D, et al. Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens. Cytometry B Clin Cytom 2012; 82:305.
- Chechani V, Allam AA, Kamholz SL. Pulmonary non-Hodgkin's lymphoma mimicking infection. Respir Med 1990; 84:401.
- Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990; 94:170.
- PATHOLOGICAL FEATURES
- CLINICAL MANIFESTATIONS
- Laboratory testing
- Pleural fluid analysis
- DIAGNOSIS OF PULMONARY PARENCHYMAL LYMPHOMA
- Transthoracic needle biopsy
- Lung biopsy
- DIAGNOSIS OF MEDIASTINAL LYMPHOMA
- DIAGNOSIS OF PLEURAL LYMPHOMA
- DIFFERENTIAL DIAGNOSIS
- SUMMARY AND RECOMMENDATIONS